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Background: Subjective tinnitus is the perception of sound in the absence of a corresponding external sound for
which there is no known medical etiology. For a minority of individuals with tinnitus, the condition impacts their
ability to lead a normal lifestyle and is severely debilitating. There is no known cure for tinnitus, so current therapy
focuses on reducing the effect of tinnitus on the patient’s quality of life. Tinnitus retraining therapy (TRT) uses
nonpsychiatric tinnitus-specific educational counseling and sound therapy in a habituation-based protocol to
reduce the patient’s tinnitus-evoked negative reaction to, and awareness of, the tinnitus, with the ultimate goal of
reducing the tinnitus impact on the patient’s quality of life. Some studies support the efficacy of TRT, but no trial to
date has compared TRT with the current standard of care or evaluated the separate contributions of TRT counseling
and sound therapy. The Tinnitus Retraining Therapy Trial (TRTT) is a randomized, double-blind, placebo-controlled,
multicenter trial for individuals with intolerable tinnitus.
Methods/design: The TRTT is enrolling active-duty and retired military personnel and their dependents with
functionally adequate hearing sensitivity and severe tinnitus at US Air Force, Navy, and Army medical centers.
Eligible study participants are randomized to TRT, partial TRT, or standard care to determine the efficacy of TRT and
its components (TRT counseling and sound therapy). The primary outcome is change in score on the Tinnitus
Questionnaire assessed longitudinally between baseline and follow-up (3, 6, 12, and 18 months following
treatment). Secondary outcomes include subscale score changes in the Tinnitus Questionnaire, overall and subscale
score changes in the Tinnitus Functional Index and Tinnitus Handicap Inventory, and change in the visual analog
scale of the TRT Interview Form. Audiological outcomes include tinnitus pitch and loudness match and measures of
loudness discomfort levels. The incidence of depression as a safety measure is assessed at each visit using the Beck
Depression Inventory Fast Screen.
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Tinnitus is the perception of sound in the absence of a
corresponding external sound for which there is no ap-
parent cause. The precise mechanisms underlying sub-
jective tinnitus are currently unknown. Almost everyone
experiences some degree of tinnitus at some time, in-
cluding sensations of ringing, buzzing, whistling, or his-
sing. The majority of persons experiencing tinnitus do
not report undue distress associated with the tinnitus or
require professional help. The prevalence of continuous
subjective tinnitus among adults ranges from 10.1 to
14.5% [1], but only about 20% of these individuals re-
quire professional help for the treatment of their tin-
nitus. For some of these individuals, the impact of
tinnitus is severely debilitating, impairing their wellbeing
and ability to lead a normal lifestyle.
Currently, there is no reliable means of ‘curing’ tin-
nitus at its source [2,3]. Evidence from Cochrane reviews
of tinnitus treatment trials indicates that no medical or
nonmedical treatment is more effective than placebo in
eliminating tinnitus. Consequently, current efforts to treat
tinnitus focus on reducing the effect of tinnitus on
health-related quality of life. Cognitive behavioral therapy,
which challenges negative feelings associated with tinnitus
and thus seeks to reduce the patient’s focus on tinnitus
and the corresponding distress, has some efficacy, as
demonstrated in a Cochrane review [4]. Tinnitus retrain-
ing therapy (TRT) also aims to reduce the focus of the
individual on his or her tinnitus and its impact on health-
related quality of life. Tinnitus retraining therapy involves
nonpsychiatric tinnitus-specific educational counseling
and low-level sound therapy to habituate the patient’s as-
sociated negative emotional reactions (for example, an-
noyance, or anxiety) to tinnitus, the perception of tinnitus
(awareness) and, ultimately, the impact of the tinnitus on
the patient’s life [5].
Tinnitus retraining therapy is based on a neurophysio-
logical model of tinnitus [6]. The model hypothesizes
that the distress associated with tinnitus arises from
abnormal subconscious nonauditory mechanisms, medi-
ated primarily by the limbic and autonomic nervous sys-
tems. Preliminary evidence from various uncontrolled
studies of individuals, who received full or partial TRT
as part of their treatment for tinnitus, consistently sup-
ports the therapeutic benefits of the full TRT protocol.
When the TRT protocol is closely followed, typical rates
of clinical success, as judged by a minimum of 20% im-
provement in two or more impact-on-life scales, ap-
proach or exceed 80% improvement [7-12]. A recent
Cochrane systematic review of TRT [13] found only one
randomized trial that adhered to the TRT protocol as
developed by Jastreboff and Hazell [7]. This trial com-
pared TRT with a tinnitus masking intervention [14].
The investigators found that both treatments wereefficacious in treating tinnitus over a treatment period
of 18 months, but that TRT resulted in greater im-
provement in patients with greater tinnitus severity at
baseline. However, the Cochrane reviewers noted the
presence of design flaws that could have resulted in
biased findings. Results from three smaller trials have
subsequently been published. Bauer and Brozoski [15]
found that both TRT and general counseling were effi-
cacious in reducing the annoyance and impact of tin-
nitus over 18 months, and that the effect size was
greater for TRT (1.13) than for general counseling
(0.78). In a second trial [16], a comparison of accept-
ance and commitment therapy with TRT showed that
acceptance and commitment therapy yielded a signifi-
cantly larger reduction in tinnitus impact than did TRT
at 10 weeks, 6 months, and 18 months of treatment.
Lastly, Tyler et al. [17] evaluated masking versus TRT
sound therapy and no sound therapy in study partici-
pants provided with an equivalent to TRT counseling.
This trial reported a positive effect of either sound
therapy or masking compared with counseling alone,
but had a high proportion of dropouts in all treatment
arms [17].
Thus, although the current literature provides some
support for the efficacy of TRT, no trial has compared
TRT with the current standard of care. The existing tri-
als all compared TRT with a treatment with unknown
efficacy. In addition, no trial has evaluated the separate
contributions of the component parts of TRT, specific-
ally tinnitus-specific educational counseling and sound
therapy. To address these gaps, we are conducting a ran-
domized, placebo-controlled, multicenter trial of TRT,
the Tinnitus Retraining Therapy Trial (TRTT), by com-
paring TRT with the current standard of care in military
hospitals, while parsing out the separate effects of TRT
counseling and sound therapy. A full description of the
rationale for the TRTT has been published previously
[18]; this paper describes the design and methods used
in the trial.
Methods/design
The primary objective of the TRTT is to assess the effi-
cacy of TRT as a treatment for severe tinnitus. Our spe-
cific goals are to evaluate the efficacy of TRT and its
component parts in habituating the perceived magnitude
(sensation), perception (awareness), and negative emo-
tional reactions (for example, annoyance, anxiety) to tin-
nitus, and to measure TRT treatment effect on the
impact of tinnitus on each participant’s health-related
quality of life.
Recruitment
The TRTT is currently being conducted at US Air Force,
Navy, and Army medical centers with active-duty and
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ment began in August 2011 at six clinical centers. One
center withdrew from recruitment in January 2013, and
two additional Army medical centers are currently under-
going certification to participate as clinical centers. As of 1
September 2014, clinical centers have enrolled 136 of the
planned 228 study participants.
Eligible study participants have subjective annoying
tinnitus of at least one year’s duration for which there is
no identified medical etiology. They have normal hearing
sensitivity of no worse than mild hearing loss through
4,000 Hz that does not require the use of hearing aids.
Eligible participants had not received treatment for their
tinnitus within the previous year. Specific inclusion and
exclusion criteria include the following:Eligibility criteria for TRTT
Inclusion criteria
 Age 18 or older.
 Primary complaint of continuous, chronic subjective
tinnitus for at least one year.
 Score on the Tinnitus Questionnaire of 40 or more.
 Functionally normal hearing sensitivity by
audiometric thresholds ≤30 dB hearing loss at and
below 2000 Hz and ≤40 dB hearing loss at 4000 Hz.
 Able to understand counseling and comprehend and
complete English language questionnaires.
 Willing and able to give informed consent.Exclusion criteria
 Predisposing disease with tinnitus symptoms
amenable to medical or surgical intervention.
 Clinical treatment for tinnitus within previous year.
 Evidence of malingering or exaggeration of tinnitus
or hearing symptoms.
 Emotional, psychological, or psychiatric condition
precluding full participation or follow-up.
 Active involvement in tinnitus-related litigation.
 Diagnosis of pulsatile tinnitus, somatosounds, or
objective tinnitus (that is, spontaneous otoacoustic
emissions) that could be responsible for the tinnitus
problem.
 Brain or head trauma requiring treatment
24 months before randomization.
 Inability to complete audiological testing or other
testing required by the clinical trial protocol.
Study candidates must also be willing and able to pro-
vide informed consent to allow determination of eligi-
bility and randomization to treatment for the TRTT.
Before entry into the TRTT, eligible candidates mustconfirm willingness to be randomized to an assigned
treatment.
Interventions of the TRTT
In the TRTT, participants have an equal probability of
assignment to one of three groups:
1. Full TRT, including tinnitus-specific educational
counseling and sound therapy implemented with
ear-level sound generators.
2. Partial TRT, including tinnitus-specific educational
counseling and sound therapy implemented with
placebo sound generators.
3. Standard care, as administered in military hospitals,
based on surveys of clinicians at participating clinics
and guidelines of the American Speech-Language
Hearing Association [19].
Differences between TRT and standard care are item-
ized in Table 1 and described in detail below.
Tinnitus-specific educational counseling
Tinnitus-specific educational counseling, as implemen-
ted in the TRTT, is based on the general principles and
methodology described by Jastreboff and Hazell [20],
which was the most comprehensive description of the
practice of TRT at the time the trial was designed. The
overall goals of TRT counseling are to educate the
participant about his or her tinnitus condition, initiate
tinnitus habituation, and, ultimately, neutralize the par-
ticipant’s negative emotional associations with his or
her tinnitus. The TRT has two primary subgoals: (1)
habituation of tinnitus-evoked negative reaction (for
example, annoyance, anxiety, or panic related to tin-
nitus) and (2) habituation of the perception (awareness
of tinnitus). Negative emotional reactions arise from
distress induced by tinnitus; TRT counseling aims to
provide information to reframe (that is, demystify) the
participants’ conscious beliefs and begin to neutralize
the participant’s negative emotional associations with
the tinnitus condition, facilitating habituation of the re-
action. Habituation of the perception of the tinnitus
signal often occurs after a sufficient level of habituation
of the reaction is achieved, and this phase of treatment
is facilitated by sound therapy.
The components of the initial TRT counseling session
include the following:
 Explanation of the results of the audiological/
tinnitus/hyperacusis clinical evaluation, with an
emphasis on the relation of the tinnitus to the
clinical findings.
 Description of the anatomy and physiology of the
normal and impaired auditory system, noting that
Table 1 Comparison of tinnitus retraining therapy and standard care in the TRTT
Topic or concept Tinnitus retraining therapy (tinnitus counseling and
sound therapy)
Standard care
Goal of counseling Introduce the concept of habituation to facilitate
habituation of reaction and secondly, habituation of
perception. The goal is for the participant to move to a
state where tinnitus is no longer an issue.
Reduce negative cognitive, affective, physical and
behavioral reactions to tinnitus; improve the
participant’s wellbeing and quality of life.
Short-term goals Reframe the way the participant views the tinnitus
problem by understanding what it is and what it is not;
neutralize negative emotional associations by
understanding the mechanisms that provoke the
emotional reaction to the tinnitus.
Empathize with and validate the participant’s feelings,
provide reassurance, promote self-efficacy and engage
participant in tinnitus management.
Baseline interview and factors
that exacerbate tinnitus
Review completed TRT Interview Form, which informs
counselor about impact of tinnitus or decreased sound
tolerance on such activities as concentration, sleep,
quiet recreational activities, work, restaurant use, sports,
concert attendance, or socializing. This information is
then discussed during counseling and at follow-up
appointments.
Elicit participant’s ‘story’ to identify problem areas.
Description of the anatomy and
physiology of the normal and
impaired auditory system
Explain structures of outer, middle, and inner ear with
special attention to the cochlear structures, function of
inner and outer hair cells, and afferent and efferent
nerve fibers, using three-dimensional model of an ear,
diagrams, and photos. Emphasize that hearing is
perceived at the brain, not at the ear, which serves only
as a transformer, changing mechanical into electrochemical
energy that the brain processes as sound.
Describe in general terms outer and inner ear and
some description of nerve pathways.
Processing at the level of the
brain
Explain that the cortical area of the brain is responsible
for the perception of sound, with monitoring by at least
five pre-cortical or subconscious lower levels to filter out
irrelevant sounds and enhance new or dangerous
signals based on personal characteristics and situation.
Describe, with examples, ways in which the brain
processes signals, including sensory contrast, selective
perception, prioritization, and relationship with tinnitus.
Not described.
Explanation of tinnitus Explain key points of Jastreboff’s neurophysiological
model of tinnitus, using basic charts, to demonstrate the
importance of the activation of subcortical, limbic and
autonomic systems in tinnitus becoming intrusive.
Provide general description, with assurances that
tinnitus is common, does not predict hearing loss, and
does not damage health.
Sound therapy Implement sound therapy with sound generators with
low-level, relatively broad-band, sound set to level
where sound just begins to mix with tinnitus sound.
Recommend environmental sound and to ‘avoid silence’
at all times.
Recommend environmental sound.
Hearing protection Recommend use of appropriate noise protection in
hazardous situations, with caveat that participant should
not overuse sound protection. Advise an increase in the
volume of the sound generator in slightly noisier
settings or the wearing of muffs over sound generators
to avoid silence.
Recommend use of appropriate noise protection in
hazardous situations. No recommendation for or
against routine sound protection.
Sleep Recommend use of environmental sound throughout
the night with tabletop sound machines or sound
pillows that have neutral sound that can be adjusted to
soft, but audible, volume (not television or talk radio).
Discuss etiology of sleep disorders as they relate to
tinnitus.
Discuss general guidelines for sleep health and,
if necessary for sleep health, recommend use of
environmental sound, if an issue. If not an issue, not
discussed.
Concentration Discuss, if an issue. Discuss ways to shift attention, increase attention span,
and avoid distraction, if an issue; if not an issue, not
discussed.
Stress Discuss, if an issue. Discuss methods to facilitate relaxation, if an issue; if
not an issue, not discussed.
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Table 1 Comparison of tinnitus retraining therapy and standard care in the TRTT (Continued)
Setting goals with individual
patient
Discuss making progress towards habituation, making
sure the patient understands that it is important not to
try to control the process or actively monitor it on a
daily basis.
Discuss coping mechanisms that have worked in the
past for the participant, including use of environmental
sound devices, and strategies to deal with sleep, stress,
and concentration. Recommend or decide upon
specific strategies for problem areas.
Written materials Provide written summary of tinnitus counseling and
guidelines for sound generator use.
Provide leaflets on tinnitus facts; environmental sound
devices; and tips for enhancing sleep, relaxation, and
concentration, if these are problem areas; provide list
of websites with additional information.
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brain, not the ear.
 Discussion of the role of the central auditory system
and higher cortical processes to interpret an
auditory signal and how this processing relates to
the participant’s tinnitus perception.
 Description of the Jastreboff neurophysiological
model of tinnitus [6], which is the centerpiece and
focus of TRT counseling in informing the participant
about the conscious and subconscious processes
involved in the generation and habituation of the
tinnitus. These key processes and components of the
model as used in the TRTT were summarized by
Formby and Scherer [18], and considered in depth
by Jastreboff and Hazell [20].
 Setting goals with and for the individual participant, by
discussing progress made towards habituation without
trying to control or actively monitor the process.
Participants are counseled individually or with family
members. The study audiologist uses a standardized
flipchart and visual aids during the TRT counseling ses-
sion to illustrate and explain the participant’s audio-
logical/tinnitus/hyperacusis results, auditory anatomy
and physiology, how the physiological processes relate
to tinnitus, the Jastreboff model of tinnitus, and other
key concepts of TRT. The counseling audiologist also
completes a checklist to ensure practitioner fidelity to
the TRTT treatment protocol for tinnitus-specific edu-
cational counseling. In the initial TRT counseling ses-
sion, which lasts for approximately two hours, the
audiologist presents information designed to help the
participant change the way in which he or she views his
or her tinnitus or decreased sound tolerance (hyperacu-
sis), addresses the individual participant’s concerns, and
recommends strategies to help the participant achieve
the long-term goal of habituation to the tinnitus. Suffi-
cient time is allowed to answer the participant’s ques-
tions and to ensure that he or she understands all
information presented, including the treatment goal of
reducing the impact of tinnitus and, if present, manage-
ment of decreased sound tolerance, in his or her life.
Follow-up contacts with participants receiving tinnitus-
specific educational counseling in the TRTT are held at asecond treatment visit one month following the initial
counseling session and at 3, 6, 12, and 18 months at the
clinical center. Follow-up sessions vary in length from
15 minutes to an hour, depending on the individual par-
ticipant’s needs; audiologists reinforce topics covered in
the initial TRT counseling session and discuss results of
follow-up interviews and tests.
Sound therapy
Sound therapy was also implemented for TRT follow-
ing the basic principles and methodology outlined by
Jastreboff and Hazell [20]. An integral part of TRT, sound
therapy aims to facilitate habituation of the perception or
awareness of the tinnitus signal by decreasing the contrast
between the tinnitus signal and background sounds.
Sound therapy is believed to decrease the perception of
the tinnitus signal by reducing the gain within the auditory
pathways, which further facilitates habituation of the
awareness of the tinnitus signal. Sound therapy for TRT
may be implemented in any form that achieves an
enriched sound environment. The most direct, consistent,
and convenient strategy for implementing sound therapy
for tinnitus participants with little or no hearing loss is the
use of a low-level, relatively broad-band, neutral sound,
produced by open-canal bilateral ear-level sound genera-
tors. This approach allows sound therapy from the sound
generators to be supplemented with environmental sound.
We have chosen this method of implementing sound ther-
apy for the TRTT because it allows us to standardize the
sound therapy administered and to isolate sound therapy
by comparing participants using conventional and placebo
sound generators.
In the TRTT, all participants are in TRT Category 1,
indicating tinnitus of high severity and no other signifi-
cant hearing problems; Category 3, indicating the pres-
ence of hyperacusis; or Category 4, with hyperacusis as
the dominant complaint and exacerbation of symptoms
for a prolonged period of time. For the TRTT, hyperacu-
sis was not an exclusion criterion, but a prospective par-
ticipant with severely debilitating hyperacusis could be
excluded at the discretion of the study audiologist if he
or she believed that sound therapy was essential for
managing the hyperacusis, thus forestalling assignment
of the prospective participant to standard care.
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ator of the Tranquil model, manufactured by General
Hearing Instruments, Inc.. Using these sound generators
allows standardization of sound therapy across partici-
pants and provides the opportunity to achieve a double-
blind placebo for sound therapy in the TRTT. General
Hearing Instruments, Inc., provide both conventional
and placebo sound generators for the TRTT.
The sound generators include data-logging capability to
monitor sound therapy use and compliance by the study
participant, and sound-level exposure to determine the na-
ture of the primary sound exposure (that is, environmental
sound or sound from the sound generators) at any point
in time. The sound generator is housed in either a behind-
the-ear or an in-the-ear device, both of which offer adjust-
ment of the output volume to a ‘zero’ (fully quiet) noise
floor. Placebo sound generators have a physical appear-
ance identical to the conventional instrument so that nei-
ther study personnel nor study participants are aware of
which sound treatment the participant is receiving. The
sound output of the placebo device is designed to be iden-
tical to the conventional device upon initial insertion into
the outer ear, but after the first 40 minutes of use, the level
of sound gradually fades to silence. Double-blinding of the
study audiologist and study participant is made possible
by a novel re-setting feature of the sound generators. Spe-
cifically, the placebo device re-sets within 3 seconds to the
full output level, as set at the beginning of initial use,
whenever the device is removed from the ear. Thus, if ei-
ther the study audiologist or study participant re-checks
the placebo output sound level, it will be heard again at
the same level as was set initially and the decay process
will begin anew. This decaying auditory process of the pla-
cebo sound generator output mimics normal auditory per-
ceptual adaptation to the ‘sea-shell’ like noise emitted by
both the conventional and placebo sound generators. The
expectation of this normal perceptual adaptation to the
noise is crucial for the success of the placebo sound gener-
ator, and reinforced by instructions to all study partici-
pants assigned to sound therapy using sound generators.
Fitting and activation of sound generators takes place
after the TRT counseling session, and typically requires
about one hour. This treatment step includes instruction
to the participant on use of and care for the instruments,
correct volume settings, schedule of use, and insertion
and removal of instruments. The instrument volume is
set using programmable software. The audiologist and
study participant work together initially to set the sound
generator volume for the ear with the most troublesome
tinnitus. Then the volume is set for the opposite ear,
aiming to match the output of both ears to achieve equal
loudness just below the ‘mixing point’. In the TRTT, the
‘mixing point’ is defined as that volume setting at which
the noise from the sound generators just starts to mix orblend with the participant’s most bothersome tinnitus
sound. The noise from the sound generator should not
change the characteristic of the tinnitus, be annoying, or
mask the tinnitus. Participants are also instructed not to
set the volume of the sound generator too close to the
threshold of hearing when first setting the volume, to
avoid augmentation of the tinnitus percept, which might
occur because of the phenomenon of ‘stochastic reson-
ance’. During the fitting session, the audiologist informs
the study participant that the sound generated by the
sound generators to achieve effective sound therapy is
typically soft, and the noise may not always be heard, es-
pecially in noisy environments. Study participants have a
range of 6 dB for resetting the output levels of their
sound generators, enabling them to adjust the volume
for perceived changes in the loudness of the tinnitus
from day to day, to maintain a constant level of effective
sound. The audiologist routinely instructs the participant
to set the volume of the sound generators when they are
first inserted into the ears and not to adjust the sound
generators afterwards. Study participants are instructed
to use the sound generator as much as possible (even all
day), or at least for a minimum of 8 hours over the
course of the day.
The use of environmental sound enrichment at all
times, including when participants use sound generators,
is also strongly recommended during TRT, both during
tinnitus-specific educational counseling and while fitting
the sound generators. Avoidance of silence at all times is
a primary tenet of TRT. Exposure to a low level of envir-
onmental sound, using a tabletop sound machine, CD
player, sound pillow, or other device, preferably with a
volume control (so that the volume is not set too low),
is emphasized for augmenting sleep when the sound
generators are not worn. Use of a television or radio is
discouraged because either can attract the attention of
the participant and impair initial efforts to fall asleep or
stay asleep through the night. Exposure to low-level en-
vironmental sound is also recommended during any
period of time when the sound generators cannot be
worn.
During the second treatment visit and at all subsequent
follow-up visits, the audiologist re-checks the sound gen-
erator volume settings with the study participant to ensure
that the appropriate volume levels are being maintained
and the sound generators are functioning properly. In
addition, the study participant may come to the clinic at
any time between visits, to adjust the sound generator vol-
ume setting to maintain the appropriate sound level in re-
lation to his or her tinnitus.
Standard care
The standard care protocol developed for the TRTT is con-
sistent with information typically provided to participants
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and with professional guidelines for tinnitus management,
as outlined in the document Preferred Practice Patterns For
the Profession of Audiology, produced by the American
Speech-Language-Hearing Association [19]. Tinnitus man-
agement in standard care is based on the individual par-
ticipant’s complaints, history, audiological evaluation, and
self-assessment. Standard care aims to reduce negative
cognitive, affective, physical, and behavioral reactions to
tinnitus and improve the participant’s wellbeing and
health-related quality of life. The following topics are ad-
dressed during standard care counseling:
 Cause, source, and audiological significance of
tinnitus.
 Use of hearing protection in noise.
 Use of environmental sounds or sound therapy
devices (not including ear-level sound generators) to
reduce tinnitus perception.
 Identification of factors that may exacerbate
tinnitus.
 Adaptive coping behaviors.
 Stress reduction.
 Strategies to minimize sleep difficulties related to
tinnitus.
The audiologist begins standard care by eliciting the
participant’s narrative and establishing a mutual under-
standing of the participant’s tinnitus problem. The audi-
ologist reiterates effective ways in which the participant
has coped with tinnitus in the past and emphasizes ways
to minimize the tinnitus impact in the future. The dis-
cussion is tailored to the individual’s specific complaints,
problem situations, coping strategies, personal prefer-
ences, and feasibility. Specific topics that may be covered
include:
 Environmental sounds, including a demonstration of
available devices (for example, CD players with
nature sounds, sound pillows), excluding ear-level
sound generators or other programmable sound
therapy treatments.
 Stress reduction, including a discussion of relaxation
exercise programs (for example, Tai Chi, yoga,
meditation, progressive muscle relaxation, and visual
imagery) with handouts and performance of a short
relaxation exercise, such as visual imagery or
progressive muscle relaxation.
 Sleep, including a review of normal sleep patterns
and factors that affect sleeping, such as stress and
emotional upheaval, environmental variables (noise,
light, temperature), irregular schedules, jet lag,
medications, caffeine, nicotine, and alcohol. The
audiologist will assist the study participant inidentifying variables that impact his or her specific
sleep difficulties and provide a set of recommenda-
tions for enhancing sleep.
 Concentration and factors that affect concentration,
including noise, temperature, distractions, lighting,
hunger, fatigue, health, boredom, stress, depression,
and tinnitus. The audiologist will recommend
various steps to increase concentration and
demonstrate attention-shifting exercises.
Not all standard care topics are covered in detail for
all participants; rather, topics are selected based on those
issues or problems that affect the individual participant.
Reinforcement counseling is conducted one month after
the initial treatment session, to review the specific recom-
mendations that were made during the initial counseling
visit and to promote self-efficacy by reinforcing the study
participant’s awareness that he or she can manage tinnitus
by incorporating those recommendations into daily living.
The follow-up counseling session will typically range from
15 to 30 minutes, with the audiologist emphasizing the
importance of the consistent use of environmental sound
devices and recommended coping strategies for problem
situations.
Monitoring treatment adherence
In the TRTT, audiologists are encouraged to perform both
TRT and standard care counseling for a number of rea-
sons. Primarily, we wished to avoid a differential counselor
effect that could contribute to the treatment effect in that
some audiologists might be better counselors overall than
others. Also, we recognized that there could be a possible
counselor effect in that some audiologists might prefer to
deliver TRT counseling over standard care or vice-versa.
Alternatively, an audiologist might be biased a priori in
the belief that TRT counseling or standard care is the su-
perior treatment. Secondly, we required that at least one
audiologist remain blinded to the counseling intervention,
that is, the noncounseling audiologist would be blinded
and responsible for measuring follow-up audiological or
other outcomes. Accordingly, because of scheduling issues
and the limited number of audiologists available to partici-
pate in the study at some clinics, it was necessary to have
all audiologists trained in both counseling methods. The
latter was an important consideration for military partici-
pation in the TRTT. Lastly, if either type of counseling
proved superior, we reasoned that it would be advanta-
geous for the audiologists to have been trained in the
superior method so that he or she could offer the coun-
seling in his or her practice subsequent to the comple-
tion of the trial.
To maintain the validity of the TRTT, however, it is crit-
ical that adherence to protocol is strictly followed for the
counseling components of TRT counseling and standard
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in the TRT counseling and standard care (for example,
recommendation for exposure to ambient low-level envir-
onmental noise), there is a real possibility of treatment
contamination. Consequently, four procedures were im-
plemented to facilitate compliance with the treatment
protocol.
 Audiologists must be certified to complete either
TRT counseling or standard care prior to providing
counseling for a study participant in the trial.
Certification requires submission of a voice
recording that is reviewed and, if acceptable,
approved by the protocol monitor. Audiologists
providing unacceptable voice recordings cannot
conduct counseling sessions in the trial.
 Audiologists are required to use treatment-specific
visual aids during the counseling session that are
matched to TRT counseling or standard care.
 Audiologists must complete a checklist during each
study TRT counseling or standard care session by
ticking topics covered or discussed in that session.
 All treatment sessions are voice recorded. Files
generated by voice recorders are submitted along
with the relevant checklist for review for compliance
with the assigned treatment study protocol.
Recordings of the first two treatment sessions of
each type of counseling conducted by an individual
audiologist are reviewed for adherence to protocol.
If no deficiencies are noted in these sessions, then
one recording from among the next five counseling
sessions is randomly selected for review as long as
adherence to the treatment protocol is maintained
by that audiologist. Nonadherence to the treatment
protocol at any one session will be followed by
retraining and subsequent review of the next two
sessions conducted by that audiologist. Continuing
noncompliance results in decertification of that
audiologist, who will not be allowed to conduct any
further counseling sessions in the trial.
Randomization
Randomization is stratified by clinical center and occurs in
blocks of random multiples of three in the TRTT. The
random order of the allocation assignments for each clinic
is generated using a computer-generated random permu-
tation. After final determination of eligibility, clinic staff
accesses the TRTT website to obtain a randomization as-
signment, designated either ‘TRT’ or ‘standard care’.
Sound generators are identified in the TRTT using se-
quential serial numbers, with conventional or placebo
sound generators identified by serial number. Prior to
the study start, General Hearing Instruments, Inc., pro-
vided a block of 600 serial numbers (300 pairs) to thedata coordinating center, to identify specific devices to
be used in the TRTT. The data coordinating center
randomly designated serial numbers to be used for con-
ventional or placebo sound generators, and provided
General Hearing Instruments, Inc., with a copy of these
assignments. General Hearing Instruments, Inc., then
manufactured the standard or placebo sound generators
as specified for each assigned serial number.
At the beginning of the study, the TRTT used behind-
the-ear devices. General Hearing Instruments, Inc., sent a
sufficient number of pairs of sound generators to the data
coordinating center to supply clinics with the first six ran-
domized treatment assignments. For assignment to TRT,
the data coordinating center placed the sound generators
within a box, matching the serial number of the sound
generators to the sound generator type (standard or pla-
cebo) for randomized treatment assignment (TRT or par-
tial TRT). Standard care assignments comprised a box
that contained a sheet of paper noting assignment to
standard care. Early in the trial, it became obvious that for
some study participants, the ‘in-use’ sensor detection tech-
nology for the behind-the-ear devices failed at an un-
acceptable rate for both conventional and placebo sound
generators. The decision was made to move from behind-
the-ear sound generators to nonoccluding in-the-ear de-
vices. The data coordinating center continues to send
boxed kits to the clinical centers, but instead of including
sound generators in the box, the data coordinating center
places a form in the box for the clinic to use to order
sound generators directly from General Hearing Instru-
ments, Inc.; the form includes the serial number for that
assignment. By including the serial number, General
Hearing Instruments, Inc., is notified which type of sound
generator (conventional or placebo) to manufacture for
that study participant, while clinic staff remain unaware of
the assignment.
Outcomes
The TRTT is using patient-reported outcome question-
naires, completed on paper, to assess tinnitus-specific
health-related quality of life, general health-related qual-
ity of life, and relevant psychological measures. All ques-
tionnaires are standardized instruments with well
documented psychometric properties. The TRTT also
collects information on audiological measures of tinnitus
pitch and loudness match and loudness discomfort levels.
Additionally, the TRTT assesses the presence of depres-
sion at each study visit as a possible adverse event.
The TRTT uses three different tinnitus-specific health-
related quality of life measurement tools: the Tinnitus
Questionnaire [21]; the Tinnitus Functional Index [22];
and the Tinnitus Handicap Inventory [23]. In addition,
the overall impact of tinnitus is assessed using the ten-
point visual analog scale of the TRT Interview Form
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3-, 6-, 12-, and 18-month follow-up visits. The three
tinnitus-specific health-related quality of life instruments
(Tinnitus Questionnaire, Tinnitus Functional Index, and
Tinnitus Handicap Inventory) are also administered at
30, 42, and 54 months by mail for study participants
agreeing to extended follow-up, to assess whether any
treatment effect is maintained over time.
The primary outcome measure selected for the TRTT is
change in score on the Tinnitus Questionnaire, assessed
longitudinally from baseline to the 18-month follow-up
visit. The 52-item Tinnitus Questionnaire features a three-
point response scale, five subscales, and excellent validity
and generalizability properties [21]. The subscales: are psy-
chological distress, intrusiveness, hearing difficulties, sleep
disturbances, and somatic complaints. The baseline score
of the Tinnitus Questionnaire determines eligibility
(score ≥40) for the TRTT and provides a value for
comparison at follow-up.
The Tinnitus Functional Index is an instrument re-
cently developed by a group of experienced tinnitus in-
vestigators funded by the Tinnitus Research Consortium
[22]. It has 25 items and an eight-factor structure, in-
cluding intrusiveness, reduced sense of control, cognitive
interference, sleep disturbance, auditory difficulties (re-
lated to tinnitus), relaxation interference, reduced quality
of life, and emotional distress. Each question on the in-
strument has a ten-point response scale (ranging from
no effect to extreme effect). The Tinnitus Functional
Index has been validated for assessing responsiveness
(that is, changes in outcomes related to treatment).
The Tinnitus Handicap Inventory, developed by Newman
et al. [23], consists of 25 items and has three factors, in-
cluding functional, emotional, and catastrophic, evaluated
using a three-point response scale.
The TRTT will also measure the overall treatment ef-
fect of the study interventions using the ten-point visual
analog scale of the TRT Interview Form, which asks the
study participant to rate the impact of tinnitus on his or
her life from ‘not at all’ to ‘as much as you can imagine’.
Because tinnitus may affect the ability of study partici-
pants to concentrate, the TRTT is also measuring cogni-
tive function with the Digit Symbol Substitution Test
[25]. This test assesses the ability of an individual to
focus attention on a task. Indirectly, this measure as-
sesses the ability of the study participant to ignore the
tinnitus signal while completing a task requiring atten-
tion and psychomotor skill. The Digit Symbol Substitu-
tion Test is administered by study staff at baseline, and
at the 6- and 18-month visits.
The TRTT collects information using two additional
health-related quality of life instruments, the Hearing
Handicap Inventory [26] and the EuroQoL [27]. The
Hearing Handicap Inventory is a ten-item instrument[26] used in the TRTT to assess the impact of hearing
loss on overall and tinnitus-related health-related quality
of life. The EuroQoL consists of five items that assess
difficulty in performing activities of daily living [27]. It
uses a three-part Likert scale and a visual analog scale
that ranges from 0 (worst imaginable health) to 100
(best imaginable health state). The Hearing Handicap In-
ventory and the EuroQoL are completed at baseline and
at 6- and 18-months follow-up visits.
The TRTT is administering three psychological instru-
ments, the State-Trait Anxiety Inventory [28], the Posi-
tive and Negative Affect Schedule [29], and the Life
Events Checklist [30], to assess personality traits or life
events that might be associated with treatment efficacy.
These instruments are administered at baseline and at
6- and 18-month follow-up visits. In addition, the
TRTT is administering the Beck Depression Inventory
Fast Screen [31] at baseline and all follow-up visits, as a
safety screen for depression.
The State-Trait Anxiety Inventory is a self-report
measure of trait anxiety (or anxiety ‘proneness’) and
state anxiety (that is, transitory anxiety experienced
under specific conditions). Participants complete both
subscales of the State-Trait Anxiety Inventory at baseline
and the state subscale at 6- and 18-month follow-up
visits. The Positive and Negative Affect Schedule con-
sists of 20 adjectives describing feelings or emotions (for
example: excited, scared, irritable, nervous), that might
change with treatment benefits. To assess life events that
could result in stress and anxiety impacting wellbeing
and possibly treatment efficacy, the TRTT also adminis-
ters the Life Events Checklist.
The Beck Depression Inventory Fast Screen is used as
a screen for depression. The TRTT requires a threshold
score of 4 or more, or endorsement (a response of 2 or
3) of suicidal thoughts or wishes, to determine the need
for further mental health evaluation. Repeated measures
of the Beck Depression Inventory Fast Screen over the
course of the TRTT will permit study participants to be
monitored for the onset of serious depression as a pos-
sible consequence of treatment or other contributing
factors.
Audiological outcomes
Audiological outcomes measured in the TRTT include
pure-tone audiometric thresholds, speech recognition
thresholds, tinnitus pitch and loudness match, and loud-
ness discomfort levels. Pure-tone and speech audiometry
are used in the TRTT to evaluate changes in the partici-
pant’s hearing sensitivity and are performed at baseline
and at 6-, 12-, and 18-month follow-up visits. Tinnitus
pitch match, which identifies the frequency or frequency
range that most closely matches the pitch of the partici-
pant’s tinnitus, and tinnitus loudness match, which
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some tinnitus, will be performed at baseline, and at 6-,
12-, and 18-month follow-up visits. Loudness discomfort
level is a measure of the sound level at which an individ-
ual first judges the loudness of a sound to cause discom-
fort. Loudness discomfort levels set the functional upper
limit of the listener’s dynamic range, that is, the range
between the hearing threshold and the loudest comfort-
ably tolerated sound. In the TRTT, loudness discomfort
levels are used to determine whether intolerance to
sound (hyperacusis) is abnormal and associated with
the participant’s tinnitus. If hyperacusis is present, the
loudness discomfort levels are used to determine the
steps required to modify the level of sound set in the
sound generators by the audiologist. Loudness discom-
fort levels are measured at every study visit. The audi-
ologist performing the audiometric tests for an
individual study participant is blinded to that partici-
pant’s treatment assignment.
Efficacy outcomes
The primary objective of the TRTT is to assess the efficacy
of TRT, achieved through TRT counseling and sound ther-
apy (provided by conventional sound generators), as a
treatment for severe debilitating tinnitus. The primary
outcome to be measured in the TRTT is the difference in
score on the Tinnitus Questionnaire between baseline and
follow-up, assessed longitudinally, after 3, 6, 12, and
18 months of treatment. The TRTT also will investigate
the efficacy of sound therapy by comparing Tinnitus
Questionnaire scores of participants assigned to conven-
tional sound generators with those assigned to placebo
sound generators, where both groups are assigned to TRT
counseling. Further, the TRTT will investigate the efficacy
of TRT counseling by comparing Tinnitus Questionnaire
scores in the group of participants assigned to TRT coun-
seling and sound therapy achieved with placebo devices
versus Tinnitus Questionnaire scores for those in the
group assigned to standard care, with the assumption that
the effect of placebo sound therapy is negligible. Secondly,
the TRTT will assess the efficacy of treatment by measur-
ing the difference between baseline and end-of-treatment
Tinnitus Questionnaire scores in the three treatment
groups.
The secondary efficacy outcomes will compare groups
by assessing end-of-treatment and longitudinal changes in
scores on the subscales of the Tinnitus Questionnaire;
total and subscales of the Tinnitus Functional Index and
Tinnitus Handicap Inventory; TRT visual analog scale;
Digit Symbol Substitution Test; and psychoacoustic mea-
sures of tinnitus pitch and loudness match and loudness
discomfort levels. Maintenance of treatment efficacy will
be assessed by comparing scores on the Tinnitus Question-
naire, Tinnitus Functional Index, and Tinnitus HandicapInventory between baseline, the 18-month follow-up
visit, and each extended follow-up visit at 30, 42, and
54 months.
Ethics
The TRTT will be conducted following the ethical prin-
ciples of the Declaration of Helsinki. This study received
ethical approval from the institutional review boards of
the University of Alabama for the chair’s office and at
the Johns Hopkins Bloomberg School of Public Health
for the data coordinating center. Institutional review
boards approving the protocol and informed consent
statement at clinical centers include: the Walter Reed
National Military Medical Center institutional review
board, the 59th Medical Wing institutional review board
(Wilford Hall Ambulatory Surgical Center and David
Grant Medical Center), clinical investigation depart-
ments at Naval Medical Center San Diego and Naval
Hospital Camp Pendleton, and the Naval Medical Center
Portsmouth institutional review board. No study partici-
pant will be enrolled in the study before informed con-
sent is obtained and documented by a signed informed
consent statement.
Sample size
We based our sample-size calculation on the difference
in Tinnitus Questionnaire scores between baseline and
18 months of follow-up (end of treatment). We con-
sulted experts familiar with the Tinnitus Questionnaire
to estimate the minimal clinically important difference
between study groups. Richard S. Hallam (who devel-
oped the Tinnitus Questionnaire) proposed, ‘An effect
size of 0.8 or perhaps 1.0 on the emotional distress sub-
scale is a reasonable criterion for [clinically] significant
change’, (personal communication). An effect size of 0.8
to 1.0 on the full Tinnitus Questionnaire would corres-
pond to a change of approximately 10 to 13 points.
Wolfgang Hiller, a researcher with extensive experience
with the Tinnitus Questionnaire stated, ‘A change of less
than 5 to 6 points does not mean much’, (personal com-
munication). Based on these considerations, we chose to
design the TRTT with sufficient power to detect a ten-
point difference for the primary comparison (that is,
between TRT and standard care) and a seven-point dif-
ference for the secondary comparisons (that is, the sep-
arate efficacies of sound therapy and TRT counseling).
We assumed a type-I error rate of 0.05, using a two-
sided test and 80% power for the secondary compari-
sons. We further assumed that a standard deviation of
12.5 would hold for all groups and that there would be
10% attrition. Accordingly, by dividing an α of 0.05
among the three comparisons and accounting for 10%
attrition, we estimated that a total of 228 study partici-
pants (76 participants in each of the three groups) will
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point difference for analyses of the TRT components,
sound therapy and TRT counseling [32]. This sample size
provides for greater than 95% power for the primary ana-
lysis (TRT versus standard care). Our sample-size estimate
is conservative because the primary outcome is a longitu-
dinal analysis, using data from follow-up visits at 3, 6, 12
and 18 months, rather than a difference in score between
two time points (that is, baseline and end of treatment at
18 months).
Data management
The TRTT clinical center staff collect study data on paper
data collection forms and enter data online using the
TRTT website. All data items are validated against criteria
specified in the data dictionary, including checks for
consistency with other responses and completeness during
data entry. Data errors or inconsistencies are flagged
and displayed immediately online during the data entry
process. Data flags require ‘immediate correction’ or may
be set as ‘warnings’ (missing data). Flags that require ‘im-
mediate correction’ do not permit submission of the form
without correction. Warnings will not disallow submission
of the form, but must be addressed in a timely manner.
Warnings are entered into an error log, and an error re-
port is produced by the system. Any variables that are
marked as possibly in error are reported to the clinical
centers. In addition, errors are detected by data coordinat-
ing center staff during routine audits, in which data on
copies of paper data collection forms are compared with
data already entered into the database. Sites make correc-
tions in the TRTT website database or verify that the in-
formation entered is correct. Any new errors generated
during editing are added to the error log. Immediately fol-
lowing completion of entry of all expected data collection
forms for an individual study participant, a set of cross-
form and cross-visit data queries will be run and the clinic
queried for inconsistencies detected. Official interim data-
sets, containing data entered ‘as of ’ a given date, are cre-
ated for monitoring purposes in conjunction with data
and safety monitoring board interim report generation.
These datasets are archived for reference in duplicate
analysis.
Security measures include password protection for
each user who is granted privileges; access is based on
‘need to know’. All elements of the database are backed
up daily and weekly onto high-capacity cassette tapes,
and monthly backups are transferred to CD media. In
addition to data kept on site, copies of weekly backups
are stored off site in a fireproof safe.
Statistical methods
Initial analyses will be descriptive in nature, using means,
standard deviations, and proportions to describe baselinecharacteristics of the study participants, both combined
and by intervention group. Distributions of continuous
variables will be examined for symmetry, and transforma-
tions will be considered for seriously skewed variables. For
continuous variables, one-way analysis of variance will be
used to compare intervention groups on demographic and
other baseline characteristics. For dichotomous or other
categorical variables, chi-square tests will be used to
compare intervention groups, and enrolled and excluded
groups. Pearson correlation coefficients will be calculated
to assess the strength of the associations among the vari-
ous outcome measures and to examine associations of
other covariates with outcome measures; potential con-
founding variables will be considered for inclusion in sec-
ondary analyses involving regression models.
The primary outcome variable will be change in the
Tinnitus Questionnaire score, using spaghetti plots for
initial exploratory analyses and longitudinal data ana-
lyses for the primary analytic method. Indicator variables
will identify treatment group, with coefficients in the
models representing the primary focus on group differ-
ences. Mean Tinnitus Questionnaire scores will be com-
pared between two treatment groups using generalized
estimating equations. The basic model will account for
effects of clinical center, treating audiologist, treatment
group, and, possibly, personality traits, as measured by
the State-Trait Anxiety Index or Positive and Negative
Affect Schedule. Other factors that might be included
are scores from the Hearing Handicap Inventory or early
completion of treatment. Similar models will be run for
the secondary objectives. These variables in the models
will be used to estimate the relation between various
personality characteristics and successful habituation to
tinnitus. Interaction terms between these participant
characteristics and treatment groups will be included, to
assess whether the effect of TRT is greater for certain
types of participant. Similar analyses will assess whether
age, sex, or other participant characteristics are predict-
ive of successful habituation with or without TRT.
For the secondary efficacy analyses, we will compare
Tinnitus Questionnaire mean scores at 18-months follow-
up (end of treatment) among treatment groups using
analysis of covariance, adjusting for baseline Tinnitus
Questionnaire scores and heterogeneity of tinnitus status
in the study population. We will also adjust for important
baseline covariates and variables that may be unbalanced
at baseline and potentially related to Tinnitus Questionnaire
score. We will also use generalized estimating equations
for this analysis.
We will use this approach with other outcome vari-
ables, including the Tinnitus Questionnaire subscales,
global and subscale scores of the Tinnitus Functional
Index, Tinnitus Handicap Inventory, and visual analog
scale of the TRT Interview Form. We will also compare
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of tinnitus pitch and loudness match, and loudness dis-
comfort levels to evaluate change across time in these
measures.
All analyses will be based on the principle of intention
to treat (that is, in the analysis study participants will be
included in the group to which they were randomized)
regardless of whether they adhered to, or completed, the
assigned treatment. For the primary outcome, the only
participants who will not be included will be those for
whom Tinnitus Questionnaire could not be assessed at
any follow-up visit due to loss to follow-up. However, we
anticipate that few, if any, participants will be unable to
complete at least one follow-up Tinnitus Questionnaire
measure. To account for missing values, we will use
multiple imputation, which assumes that missing data
are missing at random.
Organization
Organizational units of the TRTT include a study chair’s
office, a data coordinating center, clinical centers, and
various committees. The National Institute on Deafness
and Other Communication Disorders (NIDCD) at the
National Institutes of Health funds the TRTT through a
cooperative grant arrangement and provides a project
officer. Leadership in the TRTT is shared by the study
chair and the director of the data coordinating center.
The chair’s office is responsible for the overall scientific
and administrative aspects of the trial. Study personnel at
the chair’s office include the study chair, TRT and standard
care training and protocol monitors, a human research
protocol monitor, and an administrative assistant. The
chair’s office is responsible for supervision of the overall
study by integrating the activities of the data coordinating
center and clinical centers, including recruitment and
oversight of the clinical centers. The chair’s office provides
assistance to clinical centers on protocol implementation
and monitors clinical center institutional review board ap-
proval. It is charged with resolution of all technical and
scientific questions regarding clinical training and treat-
ment issues and complications. The study chair organizes
and conducts TRT and standard care training sessions.
Together with the data coordinating center, the study
chair implements quality assurance measures to monitor
treatment adherence in TRTT clinical centers. The data
coordinating center oversees scientific aspects of study de-
sign, and serves as the focus of study communications,
training, and certification of clinical staff in trial proce-
dures, protocol interpretation, data processing, data ana-
lysis, and quality assurance activities. Staff at the data
coordinating center include the director, biostatistician,
director of information management, database program-
mer, statistical programmer or analyst, project coordinator,
and research assistants. The data coordinating centerprepares, maintains, and distributes study documents, data
collection forms, and a web-based data system to process
data with computer-based randomization schedules for
each clinical center. The data coordinating center trains
clinical center staff on the study protocol, supervises
TRTT data collection and processing, and performs all
study analyses. Quality control and assurance responsi-
bilities include certification of clinical center staff and
routine monitoring of recruitment, data processing, and
adherence to study protocol. The data coordinating center
is the official TRTT archive for all study data, and will pre-
pare a public use data set of TRTT data.
Clinical center staff include at least two audiologists, a
coordinator, an otolaryngologist, or study physician, and
a data system operator. Clinical centers are responsible
for participant recruitment, treatment administration,
and follow-up according to study protocol. Data man-
agement activities at participating clinics include proper
completion of all data collection forms, transmission of
that information to the data coordinating center using
the TRTT website accurately and timely, and responses
to requests for data clarification or correction.
The TRTT has three primary standing committees: a
steering committee, an executive committee, and a data
and safety monitoring board.
Members of the steering committee include the study
chair, data coordinating center director, biostatistician,
clinical center directors, and NIDCD project officer. The
steering committee is responsible for the review and ap-
proval of trial procedures, resolution of technical or op-
erational issues, review of study progress and approval
of major changes to the study protocol. The steering
committee is also responsible for acting on advice from
the data and safety monitoring board, appointment or
termination of subcommittees, review and approval of
ancillary studies, and oversight of publication of study
findings.
The executive committee includes the study chair, data
coordinating center director, and NIDCD project officer,
and is responsible for implementation of decisions made
by the steering committee and matters affecting the day-
to-day operations of the trial.
The data and safety monitoring board is responsible
for ensuring participant safety and monitoring the over-
all performance of the trial. This board reviews the study
data, as they are collected, for evidence of harmful or
beneficial treatment effects. The members of this com-
mittee, appointed by the NIDCD, include a chair and
three additional voting members not affiliated with the
study. This committee is the only committee provided
with evidence of treatment effects while the study is still
in progress. The data and safety monitoring board usu-
ally meets twice a year, but additional meetings are
scheduled as necessary.
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All TRTT papers that describe the main results of the
TRTT (that is, comparisons of treatment groups) will
follow corporate or group authorship format, naming
‘The Tinnitus Retraining Therapy Trial Research Group’
as author, with individual investigators and clinical cen-
ter staff acknowledged. No comparison data will be
available prior to completion of the study and no clinic
may publish data obtained from their clinic independ-
ently. Writing committees for TRTT papers will include
at least one representative from the chair’s office, one
from the data coordinating center, and other study
group members based on interest and expertise. All
TRTT manuscripts will be submitted to journals com-
plying with the National Institutes of Health Public
Access Policy, and all publications will be archived in
PubMed Central, as required by this policy. Presenta-
tions at conferences describing or presenting TRTT re-
sults follow the same guidelines and require clearance by
the steering committee.Public access to protocol and data
The TRTT data will become available to outside inves-
tigators at the conclusion of the trial and following
publication of the main study findings. To protect the
confidentiality of participant data, only de-identified data
will be made available for secondary analysis. All second-
ary users of data will be asked to sign a data use agree-
ment that stipulates: confidentiality and data security
standards must be adhered to by the recipient; data are
to be used for research purposes approved by the insti-
tutional review board only; no effort will be made to
identify individual participants; and data will not be
transferred to other users by the recipient.Discussion
This report describes a randomized clinical trial that will
determine the efficacy of TRT and its component parts,
tinnitus-specific educational counseling and sound ther-
apy, compared with standard care, in a military popula-
tion. Two features of the study highlight efficiency in
design. First, we designed the trial with three arms; two
arms differ only by whether placebo or conventional
sound generators are used and the third arm is standard
care. This design allows us to make multiple compari-
sons and parse out the separate effects of the TRT com-
ponents. In addition, we are conducting the study in US
military hospitals. We chose to conduct the study in this
setting given the higher prevalence of tinnitus among in-
dividuals exposed to intense noises. Because the military
population is similar to the general population in all
other aspects, we believe that the study results will be
generally applicable.Because the TRTT is assessing tinnitus-specific health-
related quality of life using three commonly used instru-
ments (Tinnitus Questionnaire, Tinnitus Functional Index,
and Tinnitus Handicap Inventory), we will be able to as-
sess comparability across these instruments. We will also
assess whether the Digit Symbol Substitution Test is a
useful measure to assess the ability to concentrate in indi-
viduals with tinnitus.
A unique feature of the TRTT is the development of a
standardized protocol for both TRT and standard care, as
practiced in the military for persons suffering from severe
tinnitus. The TRTT developed a standardized tinnitus-
specific educational counseling component of TRT, com-
prised of scripts, a flipchart, and visual aids to be used by
all audiologists at all clinical centers. This standardized
treatment protocol allowed different audiologists across
military centers to learn and administer TRT as a treat-
ment for severe tinnitus not only within the trial, but in
their clinical practices. In addition, the TRTT investigators
engaged the assistance of General Hearing Instruments,
Inc., in the development of a placebo sound generator,
enabling measurement of the separate effects of the com-
ponent parts of the TRT intervention, tinnitus-specific
educational counseling and sound therapy. Both placebo
and conventional sound generators can be used to assess
participant compliance by recording times when the de-
vice is worn or not worn. This ability provides for the
monitoring of treatment fidelity. The TRTT investigators
also developed a standard care protocol to achieve uni-
formity in the care of tinnitus by surveying clinical centers
before the trial began and incorporating current guideline
recommendations [19]. Standardization of TRT and stand-
ard care for use in a multicenter randomized clinical trial
required the essential elements of each intervention to be
identified and standardized across different study audiolo-
gists and treatment sites. The subsequent streamlining
and distillation of the essential components meant that all
details were mandated by protocol, but allowed for indi-
vidual variation by audiologists within strict adherence to
the essential components. We hope that standardization
of the interventions for the TRTT will facilitate and exped-
ite treatment outcomes in the trial and eventually within
the clinical community if either or both TRT and standard
care prove efficacious.
Trial status
The TRTT is currently in the process of recruiting study
participants.
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